SIX •
Healthcare •
Biotechnology •
Quote as of 05/19/2026 17:31
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeSIX
Market Capitalization5,653.89 mln
Float74.74 mln
Earnings Date03/12/2026
EPS
2.02
Stretched
P / E
38.24
Overvalued
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-2.92
Likely reliable
1-Year Forecast
78.80
Fairly priced
Relative Strength
89
/ 100
Strongly outperforming
Business Description
Bachem Holding AG is a Switzerland-based manufacturer specializing in the production of complex molecules used as active ingredients in pharmaceutical drugs. Founded in 1971 and owned by Ingro Finanz AG, the company serves drug developers and biotechnology firms around the world. Bachem supports its clients across the full product lifecycle, from early research and clinical trials through to large-scale commercial manufacturing, while also providing quality control, regulatory guidance, and supply chain services.
